HC-7366

· The University of Texas MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HC-7366, covering 2026-01-15 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) [Phase 1]